MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Change In Receivables : ₺77 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Change In Receivables?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's change in receivables for the quarter that ended in Dec. 2024 was ₺268 Mil. It means MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Accounts Receivable declined by ₺268 Mil from Sep. 2024 to Dec. 2024 .

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's change in receivables for the fiscal year that ended in Dec. 2024 was ₺77 Mil. It means MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Accounts Receivable declined by ₺77 Mil from Dec. 2023 to Dec. 2024 .

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Accounts Receivable for the quarter that ended in Dec. 2024 was ₺426 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Sales Outstanding for the three months ended in Dec. 2024 was 62.37.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's liquidation value for the three months ended in Dec. 2024 was ₺444 Mil.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Change In Receivables Historical Data

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Change In Receivables Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-8.03

-36.05

-41.97

8.37

77.31

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															208.85	-127.93	67.22	-130.39	268.41

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺77 Mil.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	426.485	/	623.957	*	91
=	62.37

2. In Ben Graham's calculation of liquidation value, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's accounts receivable are only considered to be worth 75% of book value:

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	434.094	-	575.09	+	0.75 * 426.485	+	0.5 * 530.455
=	444

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900

Website

https://www.meditera.com.tr

MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines